
111.59 Delayed Data As of Jul 01 | ![]() Today’s Change | 83.86 Today|||52-Week Range 122.16 | -0.37% Year-to-Date |
The 25 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 123.24, with a high estimate of 144.36 and a low estimate of 75.43. The median estimate represents a +10.44% increase from the last price of 111.59.
The current consensus among 30 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.